Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib pediatric capsule versus commercial tablet bioequivalence study under fed conditions
NL-OMON49458Phase 1Active, not recruiting
- Sponsor
- Pfizer
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bosutinib in chronic myelogenous leukemia (CML) (2 arms), sponsored by Pfizer. Started Sep 2020; status: active, not recruiting.
02
Drugs
bosutinib
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NL-OMON49458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49458.